These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3731335)

  • 21. Synthesis of potential hypolipidemic agents. Reaction of substituted phenyl 2,3-epoxypropyl ethers with adenine, uracil, and thymine.
    DiMenna WS; Piantadosi C; Lamb RG
    J Med Chem; 1978 Oct; 21(10):1073-6. PubMed ID: 722715
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and hypolipidemic activity of diesters of arylnaphthalene lignan and their heteroaromatic analogs.
    Kuroda T; Kondo K; Iwasaki T; Ohtani A; Takashima K
    Chem Pharm Bull (Tokyo); 1997 Apr; 45(4):678-84. PubMed ID: 9145504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and quantitative structure-activity relationships of antihyperlipaemic 2-substituted thieno[3,2-d]pyrimidin-4(3H)-ones.
    Shishoo CJ; Jain KS; Rathod IS; Thakkar BJ; Brahmbhatt SB; Gandhi TP; Bangaru R; Goyal RK
    Arzneimittelforschung; 1996 Mar; 46(3):273-6. PubMed ID: 8901148
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heterocyclic analogues of chlorcyclizine with potent hypolipidemic activity.
    Ashton MJ; Ashford A; Loveless AH; Riddell D; Salmon J; Stevenson GV
    J Med Chem; 1984 Oct; 27(10):1245-53. PubMed ID: 6148419
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypolipidemic 2-[4-(1,1-dimethylethyl)phenyl]-4H-3,1-benzoxazin-4-ones. Structure-activity relationships of a novel series of high-density lipoprotein elevators.
    Fenton G; Newton CG; Wyman BM; Bagge P; Dron DI; Riddell D; Jones GD
    J Med Chem; 1989 Jan; 32(1):265-72. PubMed ID: 2909740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on hypolipidemic agents. III. Comparison of the hypolipidemic properties of 5-tridecylpyrazole-3-carboxylic acid and clofibrate.
    Seki K; Fukuda M; Isegawa J; Ohki M
    Chem Pharm Bull (Tokyo); 1984 Oct; 32(10):4103-9. PubMed ID: 6529804
    [No Abstract]   [Full Text] [Related]  

  • 27. Novel pyrimidine and 1,3,5-triazine hypolipidemic agents.
    d'Atri G; Gomarasca P; Resnati G; Tronconi G; Scolastico C; Sirtori CR
    J Med Chem; 1984 Dec; 27(12):1621-9. PubMed ID: 6502593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and hypolipidemic and antidiabetogenic activities of beta,beta,beta',beta'-tetrasubstituted, long-chain dioic acids.
    Bar-Tana J; Ben-Shoshan S; Blum J; Migron Y; Hertz R; Pill J; Rose-Khan G; Witte EC
    J Med Chem; 1989 Sep; 32(9):2072-84. PubMed ID: 2788743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microwave-assisted synthesis, hypolipidemic and hypoglycemic activity of some novel 2-(4-(2-Amino-6-(4-substituted phenyl)-pyrimidin-4-yl)-phenoxy)-2-methyl propanoic acid derivatives.
    Mokale SN; Elgire RD; Sakle NS; Shinde DB
    Arch Pharm (Weinheim); 2012 Jan; 345(1):22-7. PubMed ID: 22076967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and hypolipidemic activities of 5-thienyl-4-oxazoleacetic acid derivatives.
    Moriya T; Takabe S; Maeda S; Matsumoto K; Takashima K; Mori T; Takeyama S
    J Med Chem; 1986 Mar; 29(3):333-41. PubMed ID: 3950914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 5,5-Diaryl-2-thiohydantoins and 5,5-diaryl-N3-substituted-2-thiohydantoins as potential hypolipidemic agents.
    Tompkins JE
    J Med Chem; 1986 May; 29(5):855-9. PubMed ID: 2939244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypolipidemic activity of substituted 2-pyrrolidinones in rodents.
    Cocolas GH; Chapman JM; Voorstad PJ; Hall IH
    J Pharm Sci; 1983 Jul; 72(7):812-4. PubMed ID: 6886988
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypolipidemic activity of 4-pyrimidinecarboxylic acids in CF1 mice.
    Hall IH; Cocolas GH; Williams WL
    J Pharm Sci; 1984 Dec; 73(12):1819-20. PubMed ID: 6527265
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on antihyperlipidemic agents. III. Synthesis and biological activities of 2-chloro-3-arylpropionic acids containing a quarternary carbon atom.
    Kawamatsu Y; Asakawa H; Saraie T; Mizuno K; Imamiya E; Nishikawa K; Hamuro Y
    Arzneimittelforschung; 1980; 30(5):751-8. PubMed ID: 7190414
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of hypolipidemic drugs on hepatic CoA.
    Halvorsen O
    Biochem Pharmacol; 1983 Mar; 32(6):1126-8. PubMed ID: 6838659
    [No Abstract]   [Full Text] [Related]  

  • 36. Hypolipidemic substituted 1,3-benzodioxole-2-carboxylates.
    Grisar JM; Claxton GP; Parker RA; Palopoli FP; Kariya T
    J Med Chem; 1974 Jul; 17(7):721-5. PubMed ID: 4836402
    [No Abstract]   [Full Text] [Related]  

  • 37. Synthesis, hypoglycemic and hypolipidemic activities of novel thiazolidinedione derivatives containing thiazole/triazole/oxadiazole ring.
    Mohammed Iqbal AK; Khan AY; Kalashetti MB; Belavagi NS; Gong YD; Khazi IA
    Eur J Med Chem; 2012 Jul; 53():308-15. PubMed ID: 22575535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis of hypolipidemic silybin analog 3',4'-ethylenedioxyflavonoids.
    Litkei GY; Patonay T; Bognár R; Khilja V; Aitmambetov A; Turov A; Babichev F
    Pharmazie; 1984 Nov; 39(11):741-4. PubMed ID: 6531375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypobetalipoproteinemic agents. 3. Variation of the polycyclic portion of 4-(1-adamantyloxy)aniline.
    Heyd WE; Bell LT; Heystek JR; Schurr PE; Day CE
    J Med Chem; 1982 Sep; 25(9):1101-3. PubMed ID: 7131490
    [No Abstract]   [Full Text] [Related]  

  • 40. Synthesis of 5-aryl-6-cinnamoyl-7-methyl-flavanones as novel antioxidants and antihyperlipidemics.
    Sharma A; Anand N; Sharma R; Chaturvedi U; Khanna AK; Bhatia G; Tripathi RP
    J Enzyme Inhib Med Chem; 2012 Apr; 27(2):211-22. PubMed ID: 21657950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.